Related Experiment Video
Updated: Jul 14, 2026
11:17
Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
The Evolution and Impact of Pharmacist-Driven Antimicrobial Stewardship Programs: A Review
Shesham Kumari1, Ranjeet Kumar1, Manish Singh1
1Narayan Institute of Pharmacy, Gopal Narayan Singh University, Sasaram, Rohtas, Bihar, 821305, India.
Summary
Clinical pharmacists are vital leaders in Antimicrobial Stewardship Programs (ASPs), significantly reducing mortality, infections like C. difficile, and healthcare costs. Their evolving roles are crucial for combating antimicrobial resistance (AMR).
Area of Science:
- Infectious Diseases
- Health Services Research
- Pharmacology
Background:
- Antimicrobial resistance (AMR) is a growing global health crisis.
- Antimicrobial Stewardship Programs (ASPs) are essential for combating AMR.
- The role of clinical pharmacists in ASPs has evolved significantly.
Purpose of the Study:
- To review evidence on clinical pharmacists' leadership in ASPs.
- To highlight the expanding responsibilities of pharmacists in stewardship.
- To underscore the impact of pharmacist-led interventions on patient and economic outcomes.
Main Methods:
- Review of existing literature and guidelines.
- Analysis of pharmacist-led interventions within ASPs.
- Evaluation of clinical, microbiological, and economic outcomes.
Main Results:
- Pharmacist-led interventions, including prospective audit and feedback, reduced all-cause mortality by up to 26% and C. difficile infections by up to 32%.
- These initiatives led to shorter hospital stays (1.0-1.6 days) and significant cost savings ($200,000-$400,000 annually).
- Pharmacists have transitioned from logistical support to essential leadership roles in ASPs.
Conclusions:
- Clinical pharmacists are integral to successful ASPs, improving patient outcomes and healthcare sustainability.
- Despite challenges like resource limitations, opportunities exist for expanding pharmacist roles, including in ambulatory care and AI integration.
- Pharmacist-led stewardship is a key strategy in preserving antimicrobial effectiveness and managing healthcare systems.
Related Concept Videos
01:25Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
01:21Microbiota Modulation by Antibiotics
Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...
01:25Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
01:28Antimicrobial Effectiveness
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
01:30Development of Antibiotic Resistance
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...